AVIR
Price
$3.33
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
111 days until earnings call
MRSN
Price
$2.20
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
Earnings call today
Ad is loading...

AVIR vs MRSN

Header iconAVIR vs MRSN Comparison
Open Charts AVIR vs MRSNBanner chart's image
Atea Pharmaceuticals
Price$3.33
Change-$0.00 (-0.00%)
Volume$265.33K
CapitalizationN/A
Mersana Therapeutics
Price$2.20
Change-$0.00 (-0.00%)
Volume$1.52M
CapitalizationN/A
AVIR vs MRSN Comparison Chart
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AVIR vs. MRSN commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a StrongSell and MRSN is a Hold.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (AVIR: $3.33 vs. MRSN: $2.19)
Brand notoriety: AVIR and MRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 134% vs. MRSN: 151%
Market capitalization -- AVIR: $282.95M vs. MRSN: $322.64M
AVIR [@Biotechnology] is valued at $282.95M. MRSN’s [@Biotechnology] market capitalization is $322.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileMRSN’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • MRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, AVIR is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 2 TA indicator(s) are bullish while MRSN’s TA Score has 4 bullish TA indicator(s).

  • AVIR’s TA Score: 2 bullish, 5 bearish.
  • MRSN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MRSN is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а -0.89% price change this week, while MRSN (@Biotechnology) price change was +9.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.86%. For the same industry, the average monthly price growth was +5.66%, and the average quarterly price growth was +6.44%.

Reported Earning Dates

AVIR is expected to report earnings on Mar 04, 2025.

MRSN is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-1.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRSN($323M) has a higher market cap than AVIR($283M). AVIR YTD gains are higher at: 9.180 vs. MRSN (-5.388). MRSN has higher annual earnings (EBITDA): -99.02M vs. AVIR (-203.66M). AVIR has more cash in the bank: 502M vs. MRSN (163M). AVIR has less debt than MRSN: AVIR (2.03M) vs MRSN (32.3M). MRSN has higher revenues than AVIR: MRSN (29.9M) vs AVIR (0).
AVIRMRSNAVIR / MRSN
Capitalization283M323M88%
EBITDA-203.66M-99.02M206%
Gain YTD9.180-5.388-170%
P/E RatioN/AN/A-
Revenue029.9M-
Total Cash502M163M308%
Total Debt2.03M32.3M6%
FUNDAMENTALS RATINGS
AVIR vs MRSN: Fundamental Ratings
AVIR
MRSN
OUTLOOK RATING
1..100
825
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
9896
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
6036
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVIR's Valuation (40) in the Biotechnology industry is somewhat better than the same rating for MRSN (83). This means that AVIR’s stock grew somewhat faster than MRSN’s over the last 12 months.

MRSN's Profit vs Risk Rating (96) in the Biotechnology industry is in the same range as AVIR (98). This means that MRSN’s stock grew similarly to AVIR’s over the last 12 months.

AVIR's SMR Rating (93) in the Biotechnology industry is in the same range as MRSN (99). This means that AVIR’s stock grew similarly to MRSN’s over the last 12 months.

MRSN's Price Growth Rating (36) in the Biotechnology industry is in the same range as AVIR (60). This means that MRSN’s stock grew similarly to AVIR’s over the last 12 months.

AVIR's P/E Growth Rating (95) in the Biotechnology industry is in the same range as MRSN (100). This means that AVIR’s stock grew similarly to MRSN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRMRSN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGLSX47.160.09
+0.19%
Lord Abbett Growth Leaders R4
NILTX14.09N/A
N/A
Neuberger Berman International Sel Tr
SPFFX27.64-0.12
-0.43%
Sphere 500 Climate Fund
HADAX30.95-0.18
-0.58%
Hartford Balanced HLS IA
KTRAX10.12-0.07
-0.69%
DWS Global Income Builder A

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with INZY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-0.89%
INZY - AVIR
49%
Loosely correlated
-6.00%
HEPA - AVIR
47%
Loosely correlated
-6.44%
VIR - AVIR
47%
Loosely correlated
-6.28%
AXON - AVIR
46%
Loosely correlated
-3.38%
MGTX - AVIR
46%
Loosely correlated
-6.20%
More

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with RPTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
-13.24%
RPTX - MRSN
43%
Loosely correlated
-5.54%
VRDN - MRSN
42%
Loosely correlated
-12.72%
FATE - MRSN
41%
Loosely correlated
-7.03%
CRNX - MRSN
40%
Loosely correlated
-2.05%
AVIR - MRSN
39%
Loosely correlated
-0.89%
More